NDC 70710-1411-01 - BORTEZOMIB

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70710-1411
Requested NDC
70710-1411-01
Package NDCs from labels
70710-1411-1, 70710-1411-01
Manufacturer
Zydus Pharmaceuticals USA Inc. | Zydus Hospira Oncology Private Limited
Effective date
2024-12-05
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
BORTEZOMIB - Zydus Pharmaceuticals USA Inc. | Zydus Hospira Oncology Private LimitedZydus Pharmaceuticals USA Inc. | Zydus Hospira Oncology Private Limited2024-12-05HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70710-1411-1BORTEZOMIB3.5 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,3.53
70710-1411-1BORTEZOMIB1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70710-1411BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ZYDUS PHARMACEUTICALS USA INC.]3Current NDC, Legacy NDC, 2 package rows20241208_0eb8daef-18da-43bb-b7c6-38c4c8b5dd80.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70710-1411-1EA - Each70710-141125c976e6-04fe-44fd-a092-24f39a20c99012022-06-06

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 3 · 41 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BortezomibBORTEZOMIBMAIA Pharmaceuticals, Inc.c40e6a28-d577-43d4-bca6-bef28da1d5802021-09-22Warnings, Adverse reactionsExact identifier
unii: 69G8BD63PP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.